Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
Learn More
Medchemexpress LLC Mmc (TMZ)-TOC | >98.0% | 1725.82 | C74H99F3N20O21S2 | 10 MG
Supplier: Medchemexpress LLC HY163317A10MG
MMC(TMZ)-TOC TFA is a temozolomide delivery conjugate designed to selectively bind somatostatin receptor subtype-2 (SSTR2) and deliver TMZ to SSTR2-positive tumor cells for targeted cancer research applications.
- Targets somatostatin receptor subtype-2 (SSTR2) for receptor-mediated delivery.
- Conjugated with temozolomide to enable targeted chemotherapy delivery.
- Suitable for in vitro and in vivo cancer research studies.
- Provided as a trifluoroacetic acid (TFA) salt for improved handling and stability.
- Reported purity greater than 98%, suitable for research use.
- Available in small research quantities for preclinical experiments.
Product Title
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.
Spot an opportunity for improvement?